Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 101.51 USD 0.01% Market Closed
Market Cap: 20.2B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ZBH stock under the Base Case scenario is 173.9 USD. Compared to the current market price of 101.51 USD, Zimmer Biomet Holdings Inc is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZBH Relative Value
Base Case
173.9 USD
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.6
P/S
P/S
Price to Sales
2.6
vs History
96
vs Industry
39
Median 3Y
3.3
Median 5Y
3.6
Industry
2.2
Forward
2.5
More Details
22.4
P/E
P/E
Price to Earnings
22.4
vs History
82
vs Industry
24
Median 3Y
48.9
Median 5Y
46
Industry
21.8
Forward
12.3
More Details
13.5
P/OCF
P/OCF
Price to OCF
13.5
vs History
95
vs Industry
26
Median 3Y
16.4
Median 5Y
16.9
Industry
13.4
More Details
16
P/FCFE
P/FCFE
Price to FCFE
16
vs History
58
vs Industry
25
Median 3Y
17.3
Median 5Y
23.3
Industry
19
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
96
vs Industry
46
Median 3Y
1.9
Median 5Y
2
Industry
2.1
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
96
vs Industry
32
Median 3Y
4
Median 5Y
4.3
Industry
2.3
Forward
3.1
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
96
vs Industry
44
Median 3Y
5.6
Median 5Y
6
Industry
4.8
More Details
9.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.8
vs History
98
vs Industry
32
Median 3Y
12.7
Median 5Y
13.8
Industry
11.4
Forward
8.7
More Details
16.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.1
vs History
98
vs Industry
26
Median 3Y
21.3
Median 5Y
24.8
Industry
15.5
Forward
11.2
More Details
16.7
EV/OCF
EV/OCF
Enterprise Value to OCF
16.7
vs History
90
vs Industry
22
Median 3Y
19.6
Median 5Y
20.6
Industry
13.3
More Details
27.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.7
vs History
82
vs Industry
16
Median 3Y
31.7
Median 5Y
33.3
Industry
17.1
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
95
vs Industry
50
Median 3Y
1.4
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

ZBH Competitors Multiples
Zimmer Biomet Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zimmer Biomet Holdings Inc
NYSE:ZBH
20.2B USD 2.6 22.4 9.8 16.1
US
Abbott Laboratories
NYSE:ABT
222.5B USD 5.3 16.5 21.4 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.1B USD 9 81 37 52.2
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.2 25.4 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8.2 10.7 25.1 27.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.6B USD 9.1 40.2 28.5 31.8

See Also

Summary
ZBH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZBH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZBH stock valuation using valuation multiples.
Wall Street Estimates
ZBH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZBH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.